Volume 10, Issue 4 (2024)                   IEM 2024, 10(4): 287-296 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Qassim Mohammad S, Khazal Mohsen A, Saleh Jalil I, Akram mohsein O. Assessing the Prevalence of Bacterial Vaginosis among Infertile Women in Thi- Qar Province, Iraq. IEM 2024; 10 (4) :287-296
URL: http://iem.modares.ac.ir/article-4-74135-en.html
1- Technical Institute-Baqubah, Middle Technical University, Diyala, Iraq
2- Al-Muqdad College of Education, Diyala University, Diyala, Iraq
3- Department of Medical Laboratory Techniques, Mazaya University College, Thi-Qar, Iraq, Thi-Qar Health Directorate, Al Habbobi Teaching Hospital, Thi-Qar, Iraq , osamaakram889@gmail.com
Abstract:   (537 Views)
Background: This study aimed to elucidate the predominant bacterial species implicated in the etiology of vaginosis and to determine the most effective antimicrobial agents for their therapeutic management in Iraq.
Materials & Methods: Swab samples were collected through speculum-assisted vaginal examination. The process involved inserting a swab into the vaginal canal and rotating it for at least eight seconds before pulling it out. Standard procedures including microscopy, culture, and antibiotic sensitivity testing were applied to analyze vaginal swab samples.
Findings: Staphylococcus aureus was identified as the most common Gram-positive bacterium involved in bacterial vaginosis (44.3 %). Serratia species, were not detected at all (0.0 %). Among the Gram-negative bacteria, Klebsiella was the most prevalent bacterium (at 18.8%), followed by Escherichia coli at (18.1 %). Candida was detected in 9.4% of cases. In antibiotic susceptibility testing, S. aureus exhibited maximum resistance to imipenem (100%) and high susceptibilitye to penicillin, vancomycin, and clindamycin. Gentamicin was the most effective antibiotic against E. coli and Klebsiella spp, while vancomycin was highly effective against Candida. These results, indicate that the treatment should be directed towards the antibiotics to which the bacteria show the highest sensitivity to achieve optimal therapeutic outcomes.
Conclusion: S. aureus was identified as the most common vaginal pathogen in Thi-Qar province, followed by Klebsiella spp., and E. coli, respectively. These findings provide valuable insights into the prevalence of different bacterial species and the most effective medications. The results will be invaluable for future prospective investigations.
Full-Text [PDF 559 kb]   (31 Downloads)    
Article Type: Original Research | Subject: Bacteriology
Received: 2024/03/4 | Accepted: 2024/11/26 | Published: 2024/12/20

References
1. Ravel J, Gajer P, Abdo Z, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(14):4680-7. [DOI:10.1073/pnas.1002611107] [PMID] []
2. Zhou X. Brown C.J. Abdo Z. et al. Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J. 2007; 1: 121-133. [DOI:10.1038/ismej.2007.12] [PMID]
3. Witkin S.S. Linhares I.M. Giraldo P. Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 347-354. [DOI:10.1016/j.bpobgyn.2006.12.004] [PMID]
4. Brunham R.C. Gottlieb S.L. Paavonen J. Pelvic inflammatory disease. N Engl J Med. 2015; 372: 2039-2048. [DOI:10.1056/NEJMra1411426] [PMID]
5. Allsworth J.E. Peipert J.F. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol. 2007; 109: 114-120. [DOI:10.1097/01.AOG.0000247627.84791.91] [PMID]
6. Fredricks D.N. Fiedler T.L. Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med. 2005; 353: 1899-1911. [DOI:10.1056/NEJMoa043802] [PMID]
7. Ghiasi M, Fazaeli H, Kalhor N, Sheykh-Hasan M, Tabatabaei-Qomi R. Assessing the prevalence of bacterial vaginosis among infertile women of Qom city. Iran J Microbiol. 2014 Dec;6(6):404-8. PMID: 25926958; PMCID: PMC4411426.
8. Muzny C.A. Blanchard E. Taylor C.M. et al. Identification of key bacteria involved in the induction of incident bacterial vaginosis: a prospective study. J Infect Dis. 2018; 218: 966-978. [DOI:10.1093/infdis/jiy243] [PMID]
9. Atashili J. Poole C. Ndumbe P.M. Adimora A.A. Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22: 1493-1501. [DOI:10.1097/QAD.0b013e3283021a37] [PMID] []
10. Leitich H. Bodner-Adler B. Brunbauer M. Kaider A. Egarter C. Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol. 2003; 189: 139-147. [DOI:10.1067/mob.2003.339] [PMID]
11. Bautista, Christian T., et al. "Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections." Military Medical Research 3 (2016): 1-10.‌ [DOI:10.1186/s40779-016-0074-5] [PMID] []
12. Bautista C.T. Wurapa E.K. Sateren W.B. Morris S.M. Hollingsworth B.P. Sanchez J.L. Association of bacterial vaginosis with chlamydia and gonorrhea among women in the U.S. Army. Am J Prev Med. 2017; 52: 632-639 [DOI:10.1016/j.amepre.2016.09.016] [PMID]
13. Weström L. Joesoef R. Reynolds G. Hagdu A. Thompson S.E. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis. 1992; 19: 185-192. [DOI:10.1097/00007435-199207000-00001] [PMID]
14. Haggerty C.L. Hillier S.L. Bass D.C. Ness R.B. PID Evaluation and Clinical Health Study Investigators Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis. 2004; 39: 990-995 [DOI:10.1086/423963] [PMID]
15. Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, Hale LP, Lochs H. Adherent biofilms in bacterial vaginosis. Obstet Gynecol. 2005;106(5):1013-23. [DOI:10.1097/01.AOG.0000183594.45524.d2] [PMID]
16. Leitich H, Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol. 2007;21(3):375-90. [DOI:10.1016/j.bpobgyn.2006.12.005] [PMID]
17. Wilson JD, Ralph SG, Rutherford AJ. Rates of bacterial vaginosis in women undergoing in vitro fertilisation for different types of infertility. BJOG. 2002 Jun;109(6):714-7. doi: 10.1111/j.1471-0528.2002.01297.x. [DOI:10.1111/j.1471-0528.2002.01297.x] [PMID]
18. Jean-Pierre Menard. Antibacterial treatment of bacterial vaginosis: current and emerging therapies. Int J Womens Heaith. 2011;3:395-305.
19. Bitew A, Abebaw Y, Bekele D, Mihret A. Prevalence of bacterial vaginosis and associated risk factors among women complaining of genital tract infection. Int J Microbiol. 2017;2017:1-8. [DOI:10.1155/2017/4919404] [PMID] []
20. Nzomo J, Waiyaki P, Waihenya R. Bacterial vaginosis and correlates in women of reproductive age in Thika, Kenya. Advances in Microbiology. 2013;03(03):249-254. [DOI:10.4236/aim.2013.33036]
21. Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: an insight into the prevalence, alternative treatments regimen and it's associated resistance patterns. Microb Pathog. 2019;127:21-30. [DOI:10.1016/j.micpath.2018.11.046] [PMID]
22. Aduloju OP, Akintayo AA, Aduloju T. Prevalence of bacterial vaginosis in pregnancy in a tertiary health institution, south western Nigeria. Pan Afr Med J. 2019;33. [DOI:10.11604/pamj.2019.33.9.17926] [PMID] []
23. Kamga YM, Ngunde JP, Akoachere J-FKT. Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care at the Kumba Health District (KHD), Cameroon. BMC Pregnancy Childbirth. 2019;19:1-8. [DOI:10.1186/s12884-019-2312-9] [PMID] []
24. Bérard A, Birse K, Lamont A, et al. BV-Associated Bacteria Cause Molecular and Physiological Dysfunction of the Vaginal Epithelium. Paper presented at: AIDS Research and Human Retroviruses; 2018.
25. Nahar D, Soni G, Chand AE, Mourya S. Bacterial etiology and their antibiogram in aerobic vaginitis patients at Tertiary Care Hospital, Kota, Rajasthan. Int J Scien Stud. 2016;4(3):103-107.
26. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002;109(1):34-43. [DOI:10.1111/j.1471-0528.2002.00432.x] [PMID]
27. Krauss-Silva L, Almada-Horta A, Alves MB, Camacho KG, Moreira MEL, Braga A. Basic vaginal pH, bacterial vaginosis and aerobic vaginitis: prevalence in early pregnancy and risk of spontaneous preterm delivery, a prospective study in a low socioeconomic and multiethnic South American population. BMC Pregnancy Childbirth. 2014;14(1):107. [DOI:10.1186/1471-2393-14-107] [PMID] []
28. Nasim MJ, Witek K, Kincses A, et al. Pronounced activity of aromatic selenocyanates against multidrug resistant ESKAPE bacteria. New J Chem. 2019;43(15):6021-6031. [DOI:10.1039/C9NJ00563C]
29. Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front Microbiol. 2015;6:377. [DOI:10.3389/fmicb.2015.00377] [PMID] []
30. Mulu W, Yimer M, Zenebe Y, Abera B. Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study. BMC Women's Health. 2015;15(1):42. [DOI:10.1186/s12905-015-0197-y] [PMID] []
31. Howe R, Bitew A, Dagnew M, Tegenie B, Yeshitila B, Abate E. Bacterial profile, antibacterial susceptibility pattern and associated factors among women attending antenatal and postnatal health service at University of Gondar teaching Hospital, Northwest Ethiopia. Ethiop Med J. 2019.
32. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob. 2007;6(1):4. [DOI:10.1186/1476-0711-6-4] [PMID] []
33. Linhares I, et al. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013;13:1-14. [DOI:10.1186/1471-2334-13-19] [PMID] []
34. Venter H, Mowla R, Ohene-Agyei T, Ma S. RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition. Front Microbiol. 2015;6:377. [DOI:10.3389/fmicb.2015.00377] [PMID] []
35. Odonkor ST, Addo KK. Bacteria resistance to antibiotics: recent trends and challenges. Int J Biol Med Res. 2011;2(4):1204-1210.
36. Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc. 2018;32(1):76. [DOI:10.4103/jms.jms_25_17]
37. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79:428-432. [DOI:10.1136/pmj.79.934.428] [PMID] []
38. Aslim B, Kilic E. Some probiotic properties of vaginal lactobacilli isolated from healthy women. Jpn J Infect Dis. 2006;59:249-253. [DOI:10.7883/yoken.JJID.2006.249] [PMID]
39. Charlier C, Cretenet M, Even S, Le Loir Y. Interactions between Staphylococcus aureus and lactic acid bacteria: an old story with new perspectives. Int J Food Microbiol. 2009;131:30-39. [DOI:10.1016/j.ijfoodmicro.2008.06.032] [PMID]
40. Mibbard LT, Snyder WJ. Subgluteal and retropsoas infections in obstetrical practice. J Obstet Gynecol. 1972;39:137-139.
41. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol. 1991;165:1168-76. [DOI:10.1016/S0002-9378(12)90722-X] [PMID]
42. Hafiz S, Hafiz AN, Ali L, Chughtai AS, Memon B, Ahmad A, Hussain S, et al. Methicillin resistant Staphylococcus aureus; a multicentre study. J Pak Med Assoc. 2002;52:312-315.

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.